Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers

An early first full-time pregnancy substantially reduces the risk of developing breast cancer later in life. Extensive studies indicate that this protective effect is mediated by the pregnancy hormone human chorionic gonadotrophin (hCG). METHODS: In this proof-of-concept study 33 women with a BRCA m...

Descripción completa

Detalles Bibliográficos
Autores principales: Depypere, Herman, Su, Yanrong, Dang, Nhi, Poppe, Bruce, Stanczyk, Frank, Janssens, Jaak, Russo, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011504/
https://www.ncbi.nlm.nih.gov/pubmed/33720054
http://dx.doi.org/10.1097/CEJ.0000000000000664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011504/
https://www.ncbi.nlm.nih.gov/pubmed/33720054
http://dx.doi.org/10.1097/CEJ.0000000000000664

Ejemplares similares